Literature DB >> 9933795

Comparison of the BTA stat test with voided urine cytology and bladder wash cytology in the diagnosis and monitoring of bladder cancer.

H Leyh1, M Marberger, P Conort, C Sternberg, V Pansadoro, F Pagano, P Bassi, L Boccon-Gibod, V Ravery, U Treiber, L Ishak.   

Abstract

OBJECTIVE: To compare the BTA stat test (BTA stat), a new one-step immunochromatographic assay that can be performed in the urologist's office or in the laboratory, to voided urine cytology and bladder wash cytology (cytology) in the diagnosis and monitoring of cancer of the bladder (BC).
METHODS: BTA stat and cytology were performed in a double-blinded, prospective, clinical study on specimens from 240 subjects (68 females; mean age of subjects: 64 years) suspected of having BC.
RESULTS: In 107 subjects with final diagnoses of BC confirmed by cystoscopy or cystoscopy and biopsy, the overall sensitivities of BTA stat and cytology were 65 and 33%, respectively. For tumor grades I, II, and III, the sensitivities of BTA stat were 39, 67 and 83%, respectively. Those of cytology were 4, 20 and 69%. Nine subjects had a diagnosis of 'suspicious for bladder cancer'. The specificities of BTA stat and cytology in the 124 subjects without BC were 64 and 99%, respectively. In the subjects with a history of BC (n = 74), the specificities of BTA stat and cytology were 72 and 99%, respectively. The specificity of BTA stat was lower in subjects with benign or malignant genitourinary disease other than BC (46%) than in subjects without genitourinary disease (71%).
CONCLUSIONS: The BTA stat test is considerably more sensitive than cytology in the detection of BC and can replace cytology as an adjunct to cystoscopy in the diagnosis and follow-up of patients with BC. However, due to low specificity, BTA stat should not be used without first ruling out potential interferences such as infections, renal disease and cancer, or genitourinary trauma.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 9933795     DOI: 10.1159/000019819

Source DB:  PubMed          Journal:  Eur Urol        ISSN: 0302-2838            Impact factor:   20.096


  18 in total

1.  The role of BTA stat Test in follow-up of patients with bladder cancer: results from FinnBladder studies.

Authors:  Mika-P Raitanen
Journal:  World J Urol       Date:  2008-01-08       Impact factor: 4.226

2.  Diagnosis of bladder cancer with microelectromechanical systems-based cystoscopic optical coherence tomography.

Authors:  Hugang Ren; Wayne C Waltzer; Rahuldev Bhalla; Jingxuan Liu; Zhijia Yuan; Christopher S D Lee; Frank Darras; David Schulsinger; Howard L Adler; Jason Kim; Alek Mishail; Yingtian Pan
Journal:  Urology       Date:  2009-08-05       Impact factor: 2.649

Review 3.  Emerging Roles of Urine-Based Tumor DNA Analysis in Bladder Cancer Management.

Authors:  Aadel A Chaudhuri; Bruna Pellini; Nadja Pejovic; Pradeep S Chauhan; Peter K Harris; Jeffrey J Szymanski; Zachary L Smith; Vivek K Arora
Journal:  JCO Precis Oncol       Date:  2020-07-15

4.  Bladder cancer 2000: molecular markers for the diagnosis of transitional cell carcinoma.

Authors:  D Chao; S J Freedland; A J Pantuck; A Zisman; A S Belldegrun
Journal:  Rev Urol       Date:  2001

5.  Critical evaluation of urinary markers for bladder cancer detection and monitoring.

Authors:  Shahrokh F Shariat; Jose A Karam; Yair Lotan; Pierre I Karakiewizc
Journal:  Rev Urol       Date:  2008

Review 6.  Bladder tumor markers: from hematuria to molecular diagnostics--where do we stand?

Authors:  Samir P Shirodkar; Vinata B Lokeshwar
Journal:  Expert Rev Anticancer Ther       Date:  2008-07       Impact factor: 4.512

Review 7.  Alternatives to cytology in the management of non-muscle invasive bladder cancer.

Authors:  Gilad E Amiel; Tung Shu; Seth P Lerner
Journal:  Curr Treat Options Oncol       Date:  2004-10

8.  Comparison of the ImmunoCyt test and urinary cytology with other urine tests in the detection and surveillance of bladder cancer.

Authors:  Marieta I Toma; Martin G Friedrich; Stefan H Hautmann; K Thorsten Jäkel; Andreas Erbersdobler; Angelika Hellstern; Hartwig Huland
Journal:  World J Urol       Date:  2004-02-27       Impact factor: 4.226

9.  Bladder tumour antigen (BTA stat) test compared to the urine cytology in the diagnosis of bladder cancer: A meta-analysis.

Authors:  Aiye Guo; Xiuhua Wang; Lan Gao; Juan Shi; Changyi Sun; Zhen Wan
Journal:  Can Urol Assoc J       Date:  2014-05       Impact factor: 1.862

Review 10.  Comparison of the clinical usefulness of different urinary tests for the initial detection of bladder cancer: a systematic review.

Authors:  Alessandro Sciarra; Giovanni Di Lascio; Francesco Del Giudice; Pier Paolo Leoncini; Stefano Salciccia; Alessandro Gentilucci; Angelo Porreca; Benjamin I Chung; Giovanni Di Pierro; Gian Maria Busetto; Ettore De Berardinis; Martina Maggi
Journal:  Curr Urol       Date:  2021-03-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.